Cargando…
Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine
INTRODUCTION: The use of patients’ own cancer cells for in vitro selection of the most promising treatment is an attractive concept in personalized medicine. Human carcinoma cells from malignant pleural effusions (MPEs) are suited for this purpose since they have already adapted to the liquid enviro...
Autores principales: | Ruiz, Christian, Kustermann, Stefan, Pietilae, Elina, Vlajnic, Tatjana, Baschiera, Betty, Arabi, Leila, Lorber, Thomas, Oeggerli, Martin, Savic, Spasenija, Obermann, Ellen, Singer, Thomas, Rothschild, Sacha I., Zippelius, Alfred, Roth, Adrian B., Bubendorf, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993361/ https://www.ncbi.nlm.nih.gov/pubmed/27548442 http://dx.doi.org/10.1371/journal.pone.0160807 |
Ejemplares similares
-
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer
por: Alborelli, Ilaria, et al.
Publicado: (2019) -
Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations
por: König, David, et al.
Publicado: (2021) -
Diagnostische und prädiktive Marker in der Harntraktzytologie
por: Vlajnic, Tatjana, et al.
Publicado: (2022) -
Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients – evaluation of outcome and prognostic factors: A retrospective multicenter study
por: Fuchs, Julia, et al.
Publicado: (2021) -
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
por: Ortega Sanchez, Guacimara, et al.
Publicado: (2018)